Pharmaceutical Legislation, leaked draft documents, Board of Management, annual report 2022
RSS feed
“Our products and their therapies have a clear role to play in the face of today’s health challenges in the EU. We have a responsibility to our users to ensure the continued supply of high quality and affordable products.”
“Our products and their therapies have a clear role to play in the face of today’s health challenges in the EU. We have a responsibility to our users to ensure the continued supply of high quality and affordable products.”
“Our sector has a significant contribution to make in building an integrated and sustainable future Health Union.” David Reckeweg Lecompte, President of ECHAMP
Pharmaceutical Affairs, HMPWG, industry organisations, webinar forRegulatory Affairs Experts, Annual Report, stakeholders
Board of Management, European Stakeholder conference call, EDQM, consultation Pharmeuropa 34.4 draft monographs
A new white paper, Quelle place pour l’homéopathie dans l’offre des soins? (What is the role of homeopathy in the provision of care?), presents five concrete proposals for the role of homeopathy in the provision of care in France, outlining how it can contribute to major health issues.
ECHAMP welcomes the ruling in September by the First Senate of the Federal Constitutional Court of Germany that the newly introduced provision requiring a vet’s prescription for the use of registered, non-prescription human homeopathic remedies in animals other than livestock is a violation of basic constitutional law.
HMPWG joint meeting, quality and safety requirements, Urban waste-water treatment, Regulatory Affairs webinar 2023, ECHAMP Annual Report 2022, ECHAMP data collection, World Antimicrobial Awareness Week,
ECHAMP: its mission and goals
ECHAMP Articles of Association, April 2021
In WAAW, ECHAMP calls for further research into the role that homeopathy and anthroposophic medicine can play in reducing the problem of antimicrobial resistance.
History of EU legal and regulatory environment for homeopathic and anthroposophic medicinal products; milestones 1965-2015
The status of implementation of EU legislation for homeopathic and anthroposophic medicinal products in the EU Member States
A new market study confirms that complementary and alternative medicine is well established in Austria and interest is growing. Homeopathy is the most popular treatment.
The Austrian Agency for Scientific Integrity (OeAWI) released a statement (21 Sept 2022) concluding that “there are numerous breaches of scientific integrity” in the study from Professor Michael Frass and al.
Resources for Full Members: advocacy pack, confidential correspondance, fields of activity documents
Pharmaceutical Affairs Steering Committee, regulatory affairs webinar on quality, new draft Pharmaceutical Legislation, BPI evening event, social media campaigns, questionnaire, new internal publication
Homeopathy Research Institute’s 5th International Research Conference will be held in London 16-18 June 2023.
HRI Research in Focus articles bring highlights of homeopathy research in a brief, easy-to-understand style. The latest edition details a 2019 paper assessing homeopathic treatment of Premenstrual Syndrome (PMS).
EU policy on healthy and active ageing
The Indian Ministry of Health and Family Welfare (MoHFW) has recently released on its website a draft of the New Drugs, Medical Devices and Cosmetics Bill 2022. ECHAMP is currently analyzing the implications for homeopathic medicinal products.
Comments to the Indian authorities on the draft New Drugs, Medical Devices and Cosmetics Bill 2022
to the draft of the Indian New Drugs, Medical Devices and Cosmetics Bill
Studies confirm the high safety profile of homeopathic and anthroposophic medicines.